Calder Biosciences

New York, United States

Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines

May 2025

Seed

Biopharma Biotechnology Health Care

Top Investors

SOSV SOSV SF & NY (Fka IndieBio)National Institute on Aging National Institute of Allergy and Infectious Diseases Genesis Consortium

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Calder Biosciences

Who are Calder Biosciences's investors?

Calder Biosciences's investors include SOSV, SOSV SF & NY (Fka IndieBio), National Institute on Aging, National Institute of Allergy and Infectious Diseases, Genesis Consortium.

Where is Calder Biosciences headquartered?

Calder Biosciences is headquartered in New York, United States.

What does Calder Biosciences do?

Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines

What stage is Calder Biosciences at?

Calder Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 20, 2025.

MLA

"Calder Biosciences — Funding & Investors." VCBacked, May 20, 2025, https://www.vcbacked.co/company/calder-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2025). Calder Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/calder-biosciences

Wikipedia (cite web)

{{cite web |title=Calder Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/calder-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 20, 2025.